Skip to main content
SpringerLink
Log in

Surgical Treatment of Type 2 Diabetes in Patients with BMI Below 35: Mid-term Outcomes of the Laparoscopic Ileal Interposition Associated with a Sleeve Gastrectomy in 202 Consecutive Cases

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

The objective of this study was to evaluate the mid-term outcomes of the laparoscopic ileal interposition into the jejunum (JII-SG) or into the duodenum (DII-SG) associated with sleeve gastrectomy for type 2 diabetes mellitus (T2DM) patients with BMI below 35.

Methods

The procedures were performed on 202 consecutive patients. Mean age was 52.2 ± 7.5. Mean duration of T2DM was 9.8 ± 5.2 years. Insulin therapy was used by 41.1%. Dyslipidemia was observed in 78.2%, hypertension in 67.3%, nephropathy in 49.5%, retinopathy in 31.2%, coronary heart disease in 11.9%, and other cardiovascular events in 12.9%.

Results

Mean follow-up was 39.1 months (range, 25–61). Early and late mortality was 0.99% and 1.0%, respectively. Early reoperation was performed in 2.5%. Early and late major complications were 8.4% and 3.5%. Early most frequent complications were pneumonia and ileus. Intestinal obstruction was diagnosed in 1.5%. Mean BMI decreased from 29.7 to 23.5 kg/m2, mean fasting glucose from 202.1 to 112.2 mg/dl, and mean postprandial glucose from 263.3 to 130 mg/dl. Triglycerides diminished from a mean of 273.4 to 110.3 mg/dl and cholesterol from a mean of 204.7 to 160.1 mg/dl. Hypertension was resolved in 87.5%. Mean hemoglobin A1c (HbA1c) decreased from 8.7 to 6.2% after the JII-SG and to 5.9% following the DII-SG. HbA1c below 7% was seen in 89.9% of the patients and below 6.5% in 78.3%. Overall, 86.4% of patients were off antidiabetic medications.

Conclusion

Both JII-SG and DII-SG demonstrated to be safe, effective, and long-lasting alternatives for the treatment of T2DM patients with BMI <35. Beyond glycemic control, other benefits were achieved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature 2001;414:782–787.

    Article  PubMed  CAS  Google Scholar 

  2. Moss SE, Klein R, Klein BE. Cause specific mortality in a population-based study of diabetes. Am J Public Health 1991;81:1158–1162.

    Article  PubMed  CAS  Google Scholar 

  3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853.

    Article  Google Scholar 

  4. The ADVANCE Collaborative Group. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2008;358:2560–2572.

    Article  Google Scholar 

  5. The VADT Investigators. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. N Engl J Med 2009;360:129–139.

    Article  Google Scholar 

  6. ACCORD Study Group. Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med 2008;358:2545–2559.

    Article  Google Scholar 

  7. Sjostrom L, Lindroos AK, Peltonen M, Torgereson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom C, Sullivan M, Wedel H: Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683–2693.

    Article  PubMed  Google Scholar 

  8. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Ann Rev Med 2010;61:393–411.

    Article  PubMed  CAS  Google Scholar 

  9. Ferrannini E, Mingrone G. Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care 2009;32:514–520.

    Article  PubMed  Google Scholar 

  10. DePaula, AL, Macedo AL, Rassi N, Vencio S, Machado CA, Mota BR, Silva LQ, Halpern A, Schraibman V. Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus. Surg Endosc 2008;22:2670–2678.

    Article  PubMed  CAS  Google Scholar 

  11. DePaula AL, Macedo AL, Schraibman V, Mota BR, Vencio S. Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20–34. Surg Endosc. 2009;23(8):1724–1732.

    Article  PubMed  Google Scholar 

  12. Flatt PR. Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs? Diab Vasc Dis Res 2007;4:151–153.

    Article  PubMed  Google Scholar 

  13. Kohli R, Kirby M, Setchell KDR, Jha P, Klustaitis K, Woollett LA, Pfluger PT, Balistreri WF, Tso P, Jandacek RJ, Woods SC, Heubi JE, Tschoep MH, D’Alessio DA, Shroyer NF, Seeley RJ (2010) Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity related co-morbidities. Am J Physiol Gastrointest Liver Physiol doi:10.1152/ajpgi.00221.2010.

  14. Rubino F, Forgione A, Cummings DE, Vix M., Gnuli D, Mingrone G, Castagnet M, Marescaux J (2006) The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244:741–749.

    Article  PubMed  Google Scholar 

  15. DePaula AL, Macedo ALV, Mota BR, Schraibman V. Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21–29. Surg Endosc 2009;23:1313–1320.

    Article  PubMed  CAS  Google Scholar 

  16. De Paula AL, Stival AS, Macedo A, Ribamar J, Mancini M, Halpern A, Vencio S. Prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21–34 kg/m2. Surg Obes Relat Dis 2010;6:296–305.

    Article  PubMed  Google Scholar 

  17. Members of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: James R. Gavin III, MD, PhD (Chair), K.G.M.M. Alberti, MD, Mayer B. Davidson, MD, Ralph A. DeFronzo, MD, Allan Drash, MD, Steven G. Gabbe, MD, Saul Genuth, MD, Maureen I. Harris, PhD, MPH, Richard Kahn, PhD, Harry Keen, MD, FRCP, William C. Knowler, MD, DrPH, Harold Lebovitz, MD, Noel K. Maclaren, MD, Jerry P. Palmer, MD, Philip Raskin, MD, Robert A. Rizza, MD, and Michael P. Stern, MD. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26:S5–S20.

    Article  Google Scholar 

  18. Buse JB, Caprio S, Cefalu WT, Ceriell A, Del Prato S, Inzuchi SE, Laughlin SM, Phillips II GL, Robertson RP, Rubino F, Kahn R, Kirkman ME. How Do We Define Cure of Diabetes? Reviews/Commentaries/ADA Statements. Consensus Statement. Diabetes Care 2009;32:2133–2135.

    Article  PubMed  Google Scholar 

  19. DePaula AL, Stival AR, DePaula CC, Halpern A, Vencio S. Impact on dyslipidemia of the laparoscopic ileal interposition associated to sleeve gastrectomy in type 2 diabetic patients. J Gastrointest Surg. 2010 Aug;14(8):1319–25.

    Article  PubMed  Google Scholar 

  20. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes. N Engl J Med 2008;358:580–591.

    Article  PubMed  CAS  Google Scholar 

  21. DePaula AL, Macedo ALV, Rassi N, Machado CA, Schraibman V, Silva LQ, Halpern H. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc 2008;22:706–716.

    Article  PubMed  CAS  Google Scholar 

  22. Hari Kumar KVS, Ugale S, Gupta N, Naik V, Kumar P, Bhaskar P, Modi KD. Ileal Interposition with Sleeve Gastrectomy for Control of Type 2 Diabetes. Diabetes Technol Ther 2009; 11:785–789.

    Article  Google Scholar 

  23. Tinoco A, El-Kadre L, Aquiar L, Tinoco R, Savassi-Rocha P Short-Term and Mid-Term Control of Type 2 Diabetes Mellitus by Laparoscopic Sleeve Gastrectomy with Ileal Interposition. World J Surg 2011;35(10):2338–2244.

    Article  PubMed  Google Scholar 

  24. Goel R, Amin P, Goel M, Marik S. Early remission of type 2 diabetes mellitus by laparoscopic ileal transposition with sleeve gastrectomy surgery in 23–35 BMI patients. Int J Diabetes Dev Ctries 2011; 31(2): 91–96.

    Article  Google Scholar 

  25. Dolan K, Hatzifotis M, Newbury L. A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesitiy. Obes Surg 2004;14:165–169.

    Article  PubMed  Google Scholar 

  26. Song SH and Hardisty CA. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity. QJMed 2008;101:875–879.

    Article  CAS  Google Scholar 

  27. Salim Yusuf, Steven Hawken, Stephanie Ôunpuu, Tony Dans, Alvaro Avezum, Fernando Lanas, Matthew McQueen, Andrzej Budaj, Prem Pais, John Varigos, Liu Lisheng, on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries: case–control study. Lancet 2004;364:937–952.

    Article  PubMed  Google Scholar 

  28. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS38. BMJ 1998;317:703–713.

    Article  Google Scholar 

  29. Lindholm LD, Ibsen H, Dahlof B, Devereux RB, Beever G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristiansson K, Kederballe-Pedersen O, Niemine MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapin S Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint Reduction in Hypertension Study (LIFE): a randomized trial against atenolol. Lancet 2002;359:1004–1010.

    Article  PubMed  CAS  Google Scholar 

  30. DePaula AL, Stival AR, Halpern A, Vencio S. Thirty-Day Morbidity and Mortality of the Laparoscopic Ileal Interposition Associated with Sleeve Gastrectomy for the Treatment of Type 2 Diabetic Patients with BMI <35: An Analysis of 454 Consecutive Patients. World J of Surg 2011;35:102–108.

    Article  PubMed  Google Scholar 

  31. Gregg EW, Qiuping G, Cheng YJ, Venkat Narayan KM, Cowie CC. Mortality Trends in Men and Women with Diabetes, 1971 to 2000. Ann Intern Med 2007;147:149–155.

    PubMed  Google Scholar 

  32. Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery. Updated Position Statement on Sleeve Gastrectomy as a Bariatric Procedure. Surg Obes Relat Dis 2010; 6:1–5.

    Article  Google Scholar 

  33. Koppman JS, Li C, Gandsas A. Small Bowel Obstruction after Laparoscopic Roux-En-Y Gastric Bypass: A Review of 9,527 Patients. J Am Coll Surg 2008;206:571–584.

    Article  PubMed  Google Scholar 

  34. Liddle RA, Goldstein RB, Saxton J. Gallstone formation during weight-reduction dieting. Arch Intern Med 1989;149:1750–1753.

    Article  PubMed  CAS  Google Scholar 

  35. DePaula AL, Stival AR, Halpern A, Vencio S. Surgical Treatment of Morbid Obesity: Mid-term Outcomes of the Laparoscopic Ileal Interposition associated to a Sleeve Gastrectomy Obes Surg. 2011; 21(5): 668–675.

    Article  PubMed  Google Scholar 

  36. Nocca D, Guillaume F, Noel P, Picot MC, Aggarwal R, El Kamel M, Schaub R, de Seguin de Hons C, Renard E, Fabre JM. Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year. Obes Surg. 2011 Jun;21(6):738–43.

    Article  PubMed  Google Scholar 

  37. Benaiges D, Goday A, Ramon JM, Hernandez E, Pera M, Cano JF, Obemar Group Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up. Surg Obes Relat Dis 2011;7(5):575–580

    Article  PubMed  Google Scholar 

  38. Thulesen J, Hartmann B, Kissow H, Jeppesen PB, Orskov C, Holst JJ, Poulsen SS. Intestinal growth adaptation and GLP-2 in rats with ileal-jejunal transposition or small bowel resection. Dig Dis Sci 2001;46:379–88.

    Article  PubMed  CAS  Google Scholar 

  39. Braghetto I, Lanzarini E, Korn O, Valladares H, Molina JC, Henriquez A. Manometric changes of the lower esophageal sphincter after sleeve gastrectomy in obese patients. Obes Surg 2010;20:357–362.

    Article  PubMed  Google Scholar 

  40. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999;354:617–621.

    Article  Google Scholar 

  41. Barrett-Connor E, Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men: The Rancho Bernardo study. Diabetes Care 1998;21(8):1236–1239.

    Article  PubMed  CAS  Google Scholar 

  42. De Paula AL, Stival AR, Halpern A, Depaula CC, Mari A, Muscelli E, Vencio S, Ferrannini E Improvement in insulin sensitivity and β-cell function following ileal interposition with sleeve gastrectomy in type 2 diabetic patients: potential mechanisms.. J Gastrointest Surg. 2011 Aug;15(8):1344–53

    Article  PubMed  Google Scholar 

Download references

Conflict of interests

The authors attest that there is no conflict of interest to disclose related to this manuscript.

Author information

Authors and Affiliations

  1. Department of Surgery, Hospital de Especialidades, Av. 136, no. 961, 14° andar, Setor Marista, 74.093-250, Goiânia, Goiás, Brazil

    Aureo L. DePaula & Alessandro R. Stival

  2. Catholic University of Goiás, Goiania, Brazil

    Carolina C. L. DePaula & Sergio Vencio

  3. Department of Endocrinology, University of Sao Paulo, Sao Paulo, Brazil

    Alfredo Halpern

Authors
  1. Aureo L. DePaula
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandro R. Stival
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carolina C. L. DePaula
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alfredo Halpern
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sergio Vencio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aureo L. DePaula.

Rights and permissions

Reprints and permissions

About this article

Cite this article

DePaula, A.L., Stival, A.R., DePaula, C.C.L. et al. Surgical Treatment of Type 2 Diabetes in Patients with BMI Below 35: Mid-term Outcomes of the Laparoscopic Ileal Interposition Associated with a Sleeve Gastrectomy in 202 Consecutive Cases. J Gastrointest Surg 16, 967–976 (2012). https://doi.org/10.1007/s11605-011-1807-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-011-1807-0

Keywords

Search

Navigation